Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ROL stock price vs MPW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MPW's multiple
Needs MPW P/E.
Implied fair value · at ROL's multiple
Needs Annual EPS is negative, ROL P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ROLLINS, INC. · implied price per share
Bear
$14.27
Base
$16.97
Bull
$20.49
MEDICAL PROPERTIES TRUST INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ECOLAB INC.
ROL vs ECL
HOME DEPOT, INC.
ROL vs HD
Serve Robotics Inc. /DE/
ROL vs SERV
CINTAS CORP
ROL vs CTAS
IRON MOUNTAIN INC
ROL vs IRM
MAXIMUS, INC.
ROL vs MMS
Sabra Health Care REIT, Inc.
ROL vs SBRA
WELLTOWER INC.
ROL vs WELL
Ventas, Inc.
ROL vs VTR
NATIONAL HEALTH INVESTORS INC
ROL vs NHI
OMEGA HEALTHCARE INVESTORS INC
ROL vs OHI
LTC PROPERTIES INC
ROL vs LTC
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe balance-sheet strength and earnings quality will remain the dominant driver of relative performance, then favor ROL over MPW because ROL combines positive growth, high ROIC, and low leverage while MPW carries negative earnings and very high net debt/EBITDA.
ROL trades at $43.38, above the midpoint of its historical band and closer to the upper end of $39.04-$47.72, suggesting the market already assigns it a quality premium. MPW has no usable earnings-based valuation here because net income is negative, but the operating picture and leverage profile imply a much weaker risk-adjusted profile than ROL.
Supporting Metrics
